Luciferin References

  1. Elia, U.; Ramishetti, S.; Rosenfeld, R.; Dammes, N.; Bar-Haim, E.; Naidu, G. S.; Makdasi, E.; Yahalom-Ronen, Y.; Tamir, H.; Paran, N.; Cohen, O.; Peer, D. Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 2021.
  2. Röhner, L.; Ng, Y. L. D.; Scheffold, A.; Lindner, S.; Köpff, S.; Brandl, A.; Beilhack, A.; Krönke, J. Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of CrbnI391V. Experimental hematology. 2021, 93, 61-69.e4.
  3. Dey, P.; Wang, A.; Ziegler, Y.; Kim, S. H.; El-Ashry, D.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 2020, 12, 1.
  4. Shaashua, L.; Eckerling, A.; Israeli, B.; Yanovich, G.; Rosenne, E.; Fichman-Horn, S.; Ben Zvi, I.; Sorski, L.; Haldar, R.; Satchi-Fainaro, R.; Geiger, T.; Sloan, E. K.; Ben-Eliyahu, S. Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome. BMC biology. 2020, 18, 163.
  5. Tan, X.; Broses, L. J.; Zhou, M.; Day, K. C.; Liu, W.; Li, Z.; Weizer, A. Z.; Munson, K. A.; Khaing Oo, M. K.; Day, M. L.; Fan, X. Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice. Lab on a chip. 2020, 20, 634-646.
  6. Atkins, R. J.; Stylli, S. S.; Kurganovs, N.; Mangiola, S.; Nowell, C. J.; Ware, T. M.; Corcoran, N. M.; Brown, D. V.; Kaye, A. H.; Morokoff, A.; Luwor, R. B.; Hovens, C. M.; Mantamadiotis, T. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance. Experimental cell research. 2019, 374, 353-364.
  7. Luwor, R.; Morokoff, A. P.; Amiridis, S.; D’abaco, G.; Paradiso, L.; Stylli, S. S.; Nguyen, H. P. T.; Tarleton, M.; Young, K. A.; O’brien, T. J.; Robinson, P. J.; Chircop, M.; Mccluskey, A.; Jones, N. C. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma. Cancer Investigation. 2019, 37, 144.
  8. Riaz, M. K.; Zhang, X.; Wong, K. H.; Chen, H.; Liu, Q.; Chen, X.; Zhang, G.; Lu, A.; Yang, Z. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. IJN. 2019, Volume14, 2879.
  9. Zeng, Y.; Li, B.; Liang, Y.; Reeves, P. M.; Qu, X.; Ran, C.; Liu, Q.; Callahan, M. V.; Sluder, A. E.; Gelfand, J. A.; Chen, H.; Poznansky, M. C. Dual blockade of CXCL12‐CXCR4 and PD‐1–PD‐L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB j. 2019, 33, 6596.
  10. Hartley, M.; Eren, R. O.; Rossi, M.; Prevel, F.; Castiglioni, P.; Isorce, N.; Desponds, C.; Lye, L.; Beverley, S. M.; Drexler, S. K.; Fasel, N. Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β. Microbial cell. 2018, 5, 137-149.
  11. Castañeda-Gill, J. M.; Ranjan, A. P.; Vishwanatha, J. K. Development and Characterization of Methylene Blue Oleate Salt-Loaded Polymeric Nanoparticles and their Potential Application as a Treatment for Glioblastoma. Journal of nanomedicine & nanotechnology. 2017, 8.
  12. Castiglioni, P.; Hartley, M.; Rossi, M.; Prevel, F.; Desponds, C.; Utzschneider, D. T.; Eren, R.; Zangger, H.; Brunner, L.; Collin, N.; Zehn, D.; Kuhlmann, F. M.; Beverley, S. M.; Fasel, N.; Ronet, C. Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid. 2017.
  13. Meca-Cortés, O.; Guerra-Rebollo, M.; Garrido, C.; Borrós, S.; Rubio, N.; Blanco, J. CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice. Molecular therapy. Nucleic acids. 2017, 8, 395-403.
  14. Orive‐ramos, A.; Seoane, S.; Ocaña, A.; Pandiella, A.; Montero, J. C. Regulation of the prometastatic neuregulin– MMP 13 axis by SRC family kinases: therapeutic implications. Mol Oncol. 2017, 11, 1788.
  15. Pardi, N.; Secreto, A. J.; Shan, X.; Debonera, F.; Glover, J.; Yi, Y.; Muramatsu, H.; Ni, H.; Mui, B. L.; Tam, Y. K.; Shaheen, F.; Collman, R. G.; Karikó, K.; Danet-Desnoyers, G. A.; Madden, T. D.; Hope, M. J.; Weissman, D. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nature communications. 2017, 8, 14630.
  16. Poutou, J.; Bunuales, M.; Gonzalez-Aparicio, M.; German, B.; Zugasti, I.; Hernandez-Alcoceba, R. Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment. Journal of controlled release. 2017, 268, 247-258.
  17. Dai, J.; Hensel, J.; Wang, N.; Kruithof-de Julio, M.; Shiozawa, Y. Mouse models for studying prostate cancer bone metastasis. BoneKEy reports. 2016, 5, 777.
  18. Hansen, A. H.; Lomholt, M. A.; Hansen, P. L.; Mouritsen, O. G.; Arouri, A. Optimization and modeling of the remote loading of luciferin into liposomes. International journal of pharmaceutics. 2016, 508, 128-134.
  19. Konduri, V.; Li, D.; Halpert, M. M.; Liang, D.; Liang, Z.; Chen, Y.; Fisher, W. E.; Paust, S.; Levitt, J. M.; Yao, Q. C.; Decker, W. K. Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53−/−pancreatic ductal adenocarcinoma. OncoImmunology. 2016, 5.
  20. Wang, W.; Belosay, A.; Yang, X.; Hartman, J. A.; Song, H.; Urszula, •; Iwaniec, T.; Turner, R. T.; Churchwell, M. I.; Daniel, •; Doerge, R.; Helferich, W. G. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells. Clin Exp Metastasis. 2016, 33, 475.
  21. Arouri, A.; Trojnar, J.; Schmidt, S.; Hansen, A. H.; Mollenhauer, J.; Mouritsen, O. G. Development of a Cell-Based Bioassay for Phospholipase A2-Triggered Liposomal Drug Release. PloS one. 2015, 10, e0125508.
  22. Hansen, A. H.; Mouritsen, O. G.; Arouri, A. Enzymatic action of phospholipase A.sub.2 on liposomal drug delivery systems. International journal of pharmaceutics. 2015, 491, 49.
  23. Luker, K. E.; Pata, P.; Shemiakina, I. I.; Pereverzeva, A.; Stacer, A. C.; Shcherbo, D. S.; Pletnev, V. Z.; Skolnaja, M.; Lukyanov, K. A.; Luker, G. D.; Pata, I.; Chudakov, D. M. Comparative study reveals better far-red fluorescent protein for whole body imaging. Scientific reports. 2015, 5, 10332.
  24. Mckenna, M. K.; Gachuki, B. W.; Alhakeem, S. S.; Oben, K. N.; Rangnekar, V. M.; Gupta, R. C.; Bondada, S. Anti-cancer activity of withaferin A in B-cell lymphoma. Cancer Biology & Therapy. 2015, 16, 1088.
  25. Pardi, N.; Tuyishime, S.; Muramatsu, H.; Kariko, K.; Mui, B. L.; Tam, Y. K.; Madden, T. D.; Hope, M. J.; Weissman, D. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. Journal of controlled release. 2015, 217, 345-351.
  26. Yang, X.; Belosay, A.; Hartman, J.; Song, H.; Zhang, Y.; Wang, W.; Doerge, D.; Helferich, W. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors. Clin Exp Metastasis. 2015, 32, 323-333.
  27. Bournazos, S.; Klein, F.; Pietzsch, J.; Seaman, M. S.; Nussenzweig, M. C.; Ravetch, J. V. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell (Cambridge). 2014, 158, 1243-1253.
  28. Harari, D.; Abramovich, R.; Zozulya, A.; Smith, P.; Pouly, S.; Köster, M.; Hauser, H.; Schreiber, G. Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response. PLoS ONE. 2014, 9.
  29. Tongers, J.; Webber, M. J.; Vaughan, E. E.; Sleep, E.; Renault, M.; Roncalli, J. G.; Klyachko, E.; Thorne, T.; Yu, Y.; Marquardt, K.; Kamide, C. E.; Ito, A.; Misener, S.; Millay, M.; Liu, T.; Jujo, K.; Qin, G.; Losordo, D. W.; Stupp, S. I.; Kishore, R. Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix. Journal of molecular and cellular cardiology. 2014, 74, 231-239.
  30. Kalber, T. L.; Campbell-Washburn, A. E.; Siow, B. M.; Sage, E.; Price, A. N.; Ordidge, K. L.; Walker-Samuel, S.; Janes, S. M.; Lythgoe, M. F. Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastases. PloS one. 2013, 8, e54903.
  31. Lee, S. K.; Tung, C. A Fabricated siRNA Nanoparticle for Ultralong Gene Silencing In Vivo. Advanced Functional Materials. 2013, 23, 3488-3493.
  32. Yang, X.; Belosay, A.; Du, M.; Fan, T.; Turner, R.; Iwaniec, U.; Helferich, W. Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clin Exp Metastasis. 2013, 30, 711-721.
  33. Biron-Pain, K.; St-Pierre, Y. Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model. Cell. Mol. Life Sci. 2012, 69, 783-791.
  34. Apte, S. H.; Groves, P. L.; Roddick, J. S.; P. da Hora, V.; Doolan, D. L. High-throughput multi-parameter flow-cytometric analysis from micro-quantities of Plasmodium-infected blood. International journal for parasitology. 2011, 41, 1285-1294.
  35. Lee, S. K.; Han, M. S.; Asokan, S.; Tung, C. Effective Gene Silencing by Multilayered siRNA-Coated Gold Nanoparticles. Small (Weinheim an der Bergstrasse, Germany). 2011, 7, 364-370.
  36. Sottnik, J.; Lori, J.; Rose, B.; Thamm, D. Glycolysis inhibition by 2-deoxy-d-glucose reverts the metastatic phenotype in vitro and in vivo. Clin Exp Metastasis. 2011, 28, 865-875.
  37. BOUCHARD, F.; BELANGER, S. D.; BIRON-PAIN, K.; ST-PIERRE, Y. EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth. Blood. 2010, 116, 759-766.
  38. Sottnik, J. L.; Duval, D. L.; Ehrhart, E. J.; Thamm, D. H. An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis. Clinical & experimental metastasis. 2010, 27, 151-160.
  39. Webber, M. J.; Tongers, J.; Renault, M.; Roncalli, J. G.; Losordo, D. W.; Stupp, S. I. Development of bioactive peptide amphiphiles for therapeutic cell delivery. Acta biomaterialia. 2010, 6, 3-11.
  40. Ignowski, J. M.; Schaffer, D. V. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnology and bioengineering. 2004, 86, 827-834.